X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5829) 5829
Publication (216) 216
Book Review (89) 89
Magazine Article (59) 59
Newsletter (57) 57
Book Chapter (30) 30
Newspaper Article (12) 12
Trade Publication Article (8) 8
Book / eBook (5) 5
Dissertation (4) 4
Conference Proceeding (1) 1
Government Document (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4769) 4769
female (3232) 3232
antiemetics - therapeutic use (2850) 2850
male (2641) 2641
adult (2247) 2247
antiemetics - administration & dosage (2061) 2061
middle aged (2053) 2053
index medicus (1805) 1805
nausea (1647) 1647
vomiting - chemically induced (1490) 1490
vomiting - prevention & control (1442) 1442
aged (1407) 1407
antiemetics (1256) 1256
ondansetron (1187) 1187
vomiting (1176) 1176
nausea - chemically induced (1168) 1168
oncology (1113) 1113
nausea - prevention & control (1101) 1101
double-blind method (1079) 1079
prevention (1067) 1067
chemotherapy (1022) 1022
antineoplastic agents - adverse effects (1004) 1004
antiemetics - adverse effects (979) 979
pharmacology & pharmacy (914) 914
double-blind (890) 890
anesthesiology (873) 873
vomiting - drug therapy (858) 858
postoperative nausea and vomiting - prevention & control (806) 806
treatment outcome (763) 763
dexamethasone (755) 755
nausea - drug therapy (736) 736
cancer (714) 714
adolescent (706) 706
prospective studies (679) 679
animals (659) 659
drug therapy, combination (650) 650
ondansetron - therapeutic use (627) 627
metoclopramide (618) 618
emesis (550) 550
surgery (550) 550
neoplasms - drug therapy (547) 547
medicine & public health (533) 533
child (531) 531
antiemetics - pharmacology (523) 523
efficacy (513) 513
ondansetron - administration & dosage (509) 509
dexamethasone - administration & dosage (471) 471
dexamethasone - therapeutic use (468) 468
dose-response relationship, drug (467) 467
administration, oral (465) 465
cisplatin - adverse effects (458) 458
risk factors (436) 436
antineoplastic combined chemotherapy protocols - adverse effects (428) 428
postoperative nausea (428) 428
time factors (417) 417
granisetron (415) 415
cisplatin (405) 405
drug therapy (391) 391
drug administration schedule (383) 383
anesthesia (381) 381
care and treatment (372) 372
health care sciences & services (366) 366
child, preschool (363) 363
metoclopramide - therapeutic use (361) 361
injections, intravenous (354) 354
aged, 80 and over (344) 344
children (339) 339
droperidol (338) 338
pain medicine (329) 329
aprepitant (326) 326
metoclopramide - administration & dosage (326) 326
dosage and administration (325) 325
antiemetic (312) 312
nursing (312) 312
serotonin antagonists - therapeutic use (312) 312
medicine, general & internal (308) 308
prophylaxis (308) 308
pregnancy (301) 301
rehabilitation (301) 301
analysis (298) 298
moderately emetogenic chemotherapy (292) 292
vomiting - etiology (291) 291
gastrointestinal agents (290) 290
cisplatin-induced emesis (287) 287
pediatrics (287) 287
young adult (287) 287
antineoplastic combined chemotherapy protocols - therapeutic use (286) 286
pain (285) 285
chemotherapy-induced nausea (276) 276
health aspects (274) 274
complications and side effects (266) 266
research (265) 265
retrospective studies (265) 265
postoperative nausea and vomiting (264) 264
antiemetics - pharmacokinetics (262) 262
postoperative nausea and vomiting - drug therapy (256) 256
palonosetron (255) 255
infusions, intravenous (249) 249
granisetron - administration & dosage (243) 243
chemotherapy-induced nausea and vomiting (242) 242
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5454) 5454
Japanese (172) 172
German (123) 123
French (67) 67
Spanish (37) 37
Russian (31) 31
Italian (22) 22
Danish (17) 17
Chinese (14) 14
Norwegian (9) 9
Hungarian (8) 8
Dutch (7) 7
Portuguese (5) 5
Korean (4) 4
Polish (4) 4
Serbian (3) 3
Swedish (3) 3
Turkish (3) 3
Romanian (2) 2
Bulgarian (1) 1
Czech (1) 1
Finnish (1) 1
Lithuanian (1) 1
Persian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Supportive Care in Cancer, ISSN 0941-4355, 6/2013, Volume 21, Issue 6, pp. 1655 - 1663
Olanzapine has been shown to be a safe and effective agent for the prevention of chemotherapy-induced nausea and vomiting (CINV). Olanzapine may also be an... 
Breakthrough nausea and emesis | Pain Medicine | Chemotherapy | Nursing | Rehabilitation Medicine | Olanzapine | Medicine & Public Health | Oncology | Metoclopramide | Nursing Management/Nursing Research | PREVENTION | APREPITANT | PROPHYLAXIS | ANTIEMETIC ACTIVITY | CANCER-PATIENTS | INDUCED EMESIS | CISPLATIN | ONCOLOGY | HEALTH CARE SCIENCES & SERVICES | DOUBLE-BLIND | REHABILITATION | PALONOSETRON | QUALITY-OF-LIFE | Cyclophosphamide - administration & dosage | Isoquinolines - adverse effects | Nausea - chemically induced | Humans | Middle Aged | Antiemetics - administration & dosage | Dexamethasone - adverse effects | Male | Antineoplastic Agents - administration & dosage | Cyclophosphamide - adverse effects | Quinuclidines - administration & dosage | Cisplatin - administration & dosage | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Antiemetics - adverse effects | Female | Nausea - drug therapy | Vomiting - prevention & control | Quinuclidines - adverse effects | Doxorubicin - administration & dosage | Dexamethasone - administration & dosage | Double-Blind Method | Morpholines - administration & dosage | Metoclopramide - administration & dosage | Vomiting - drug therapy | Neoplasms - drug therapy | Nausea - prevention & control | Vomiting - chemically induced | Metoclopramide - adverse effects | Cisplatin - adverse effects | Benzodiazepines - administration & dosage | Aged | Benzodiazepines - adverse effects | Isoquinolines - administration & dosage | Doxorubicin - adverse effects | Care and treatment | Cyclophosphamide | Anthracyclines | Dexamethasone | Nausea | Cancer | Side effects | Drug therapy | Vomiting | Index Medicus
Journal Article
International Journal of Pharmaceutics, ISSN 0378-5173, 2007, Volume 337, Issue 1, pp. 1 - 24
Interest in intranasal (IN) administration as a non-invasive route for drug delivery continues to grow rapidly. The nasal mucosa offers numerous benefits as a... 
Intranasal drug delivery | Pharmacokinetics | Nasal mucosa | Physicochemical properties | IN-VIVO BIOAVAILABILITY | DEPENDENT DIABETIC-PATIENTS | DIMETHYL-BETA-CYCLODEXTRIN | DIFFERENT MOLECULAR-WEIGHTS | NORKETAMINE PLASMA-CONCENTRATIONS | intranasal drug delivery | physicochemical properties | pharmacokinetics | nasal mucosa | PHARMACOLOGY & PHARMACY | CENTRAL-NERVOUS-SYSTEM | ACUTE CHILDHOOD SEIZURES | CSF FOLLOWING INTRANASAL | NASAL DRUG-DELIVERY | WATER-SOLUBLE COMPOUNDS | Cholinesterase Inhibitors - pharmacokinetics | Hypnotics and Sedatives - chemistry | Central Nervous System - metabolism | Molecular Weight | Humans | Vaccines - pharmacokinetics | Cholinesterase Inhibitors - chemistry | Hypnotics and Sedatives - administration & dosage | Antiemetics - administration & dosage | Analgesics - pharmacokinetics | Antiemetics - pharmacokinetics | Inflammation - metabolism | Vaccines - chemistry | Cardiovascular Agents - pharmacokinetics | Drug Compounding | Antiemetics - chemistry | Nasal Mucosa - metabolism | Cardiovascular Agents - administration & dosage | Drug Administration Schedule | Hypnotics and Sedatives - pharmacokinetics | Drug Stability | Solubility | Analgesics - administration & dosage | Administration, Intranasal | Chemistry, Pharmaceutical | Carrier Proteins - metabolism | Cholinesterase Inhibitors - administration & dosage | Analgesics - chemistry | Hydrophobic and Hydrophilic Interactions | Vaccines - administration & dosage | Cardiovascular Agents - chemistry
Journal Article
European Journal of Clinical Pharmacology, ISSN 0031-6970, 11/2012, Volume 68, Issue 11, pp. 1465 - 1472
Buspirone, a partial 5HT1A agonist and D2 and D3 antagonist, has shown promising antiemetic efficacy when given parenterally in animal models, but its efficacy... 
Biomedicine | Buspirone | Pharmacology/Toxicology | Randomised clinical trial | Antiemetic | Postoperative nausea and vomiting | CATS | MANAGEMENT | 5-HT1A RECEPTORS | ONDANSETRON | AGONISTS | FLESINOXAN | PROPHYLAXIS | ANXIOLYTICS | PHARMACOLOGY & PHARMACY | 5-HT(1A) RECEPTOR | CISPLATIN-INDUCED EMESIS | Anti-Anxiety Agents - administration & dosage | Injections, Intravenous | Buspirone - blood | Dopamine Antagonists - pharmacokinetics | Humans | Middle Aged | Receptors, Dopamine D3 - metabolism | Antiemetics - administration & dosage | Male | Buspirone - pharmacokinetics | Receptors, Dopamine D2 - metabolism | Dopamine Antagonists - administration & dosage | Incidence | Dose-Response Relationship, Drug | Young Adult | Anti-Anxiety Agents - pharmacokinetics | Buspirone - administration & dosage | Antiemetics - pharmacokinetics | Antiemetics - therapeutic use | Aged, 80 and over | Adult | Anti-Anxiety Agents - adverse effects | Antiemetics - adverse effects | Female | Anti-Anxiety Agents - therapeutic use | Buspirone - adverse effects | Receptors, Dopamine D3 - antagonists & inhibitors | Buspirone - therapeutic use | Receptor, Serotonin, 5-HT1A - metabolism | Postoperative Nausea and Vomiting - epidemiology | Double-Blind Method | Dopamine Antagonists - therapeutic use | Serotonin 5-HT1 Receptor Agonists - therapeutic use | Serotonin 5-HT1 Receptor Agonists - adverse effects | Postoperative Nausea and Vomiting - prevention & control | Receptor, Serotonin, 5-HT1A - chemistry | Buspirone - analogs & derivatives | Dopamine Antagonists - adverse effects | Serotonin 5-HT1 Receptor Agonists - administration & dosage | Aged | Dopamine D2 Receptor Antagonists | Postoperative Nausea and Vomiting - blood | Prevention | Complications and side effects | Buspirone hydrochloride | Adults | Nausea | Analysis | Postoperative period | Vomiting | Clinical trials | Pharmacology | Drug therapy | Clinical outcomes
Journal Article
European Spine Journal, ISSN 0940-6719, 9/2013, Volume 22, Issue 9, pp. 2089 - 2096
Major spine surgery with multilevel instrumentation is followed by large amount of opioid consumption, significant pain and difficult mobilization in a... 
Mobilization | Surgical Orthopedics | Medicine & Public Health | Opioid consumption | Multimodal pain treatment | Major spine surgery | Neurosurgery | MORPHINE | FUSION SURGERY | METHYLPREDNISOLONE | TRENDS | CLINICAL NEUROLOGY | ISSUES | RECOVERY | TOTAL DISC REPLACEMENT | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | PLACEBO-CONTROLLED TRIAL | ORTHOPEDICS | Acetaminophen - adverse effects | Postoperative Nausea and Vomiting - chemically induced | Pain, Postoperative - drug therapy | Humans | Middle Aged | Acetaminophen - administration & dosage | Antiemetics - administration & dosage | Dexamethasone - adverse effects | Male | gamma-Aminobutyric Acid - administration & dosage | Spinal Fusion - adverse effects | Case-Control Studies | Young Adult | Analgesics, Opioid - adverse effects | Analgesics, Non-Narcotic - adverse effects | Aged, 80 and over | Amines - administration & dosage | Adult | Antiemetics - adverse effects | Female | Amines - adverse effects | Drug Therapy, Combination | gamma-Aminobutyric Acid - adverse effects | Spinal Diseases - surgery | Dexamethasone - administration & dosage | Cyclohexanecarboxylic Acids - adverse effects | Cyclohexanecarboxylic Acids - administration & dosage | Analgesics, Non-Narcotic - administration & dosage | Postoperative Nausea and Vomiting - drug therapy | Analgesics, Opioid - administration & dosage | Adolescent | Aged | Care and treatment | Pain | Corticosteroids | Anesthesia | Morphine | Nausea | Chronic pain | Original
Journal Article
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2016, Volume 57, pp. 23 - 30
Abstract Objective Rolapitant, a novel neurokinin-1 receptor antagonist (RA), was shown to protect against delayed chemotherapy-induced nausea and vomiting... 
Hematology, Oncology and Palliative Medicine | Multiple cycles | Rolapitant | Neurokinin-1 receptor antagonist | Antiemetic | Chemotherapy-induced nausea and vomiting | Subsequent cycles | DEXAMETHASONE | PHASE-III | APREPITANT | ORAL NK1 ANTAGONIST | CANCER | RECEPTOR ANTAGONIST | CISPLATIN-BASED CHEMOTHERAPY | PHARMACOKINETICS | ONCOLOGY | DOUBLE-BLIND | ANTIEMETICS PROVIDES PROTECTION | Granisetron - administration & dosage | Nausea - chemically induced | Humans | Middle Aged | Antiemetics - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Spiro Compounds - administration & dosage | Male | Spiro Compounds - adverse effects | Serotonin 5-HT3 Receptor Antagonists - administration & dosage | Young Adult | Clinical Trials, Phase III as Topic | Aged, 80 and over | Adult | Antiemetics - adverse effects | Female | Drug Therapy, Combination | Vomiting - prevention & control | Granisetron - adverse effects | Dexamethasone - administration & dosage | Neurokinin-1 Receptor Antagonists - adverse effects | Double-Blind Method | Administration, Oral | Ondansetron - administration & dosage | Neurokinin-1 Receptor Antagonists - administration & dosage | Treatment Outcome | Neoplasms - drug therapy | Randomized Controlled Trials as Topic | Nausea - prevention & control | Retreatment | Vomiting - chemically induced | Aged | Ondansetron - adverse effects | Clinical Trials, Phase II as Topic | Prevention | Medical colleges | Chemotherapy | Nausea | Analysis | Cancer | Index Medicus
Journal Article
Journal Article
Journal Article
Annals of Oncology, ISSN 0923-7534, 06/2015, Volume 26, Issue 6, pp. 1248 - 1253
Journal Article